Dual-targeted injection poised to rock GLP-1 field in diabetes—and eventually weight loss.
Isabella Ciccone
Advertisement
Isabella Ciccone served as Pharm Exec’s 2022 summer editorial intern and is now an Assistant Editor for Neurology Live.
Articles by Isabella Ciccone
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
